Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

It’s the sunflower time of year, as the flowers spangle yards and roadsides and meadows in gold. But have you ever studied those gorgeous orbs up close? As sunflowers go to seed, the flower heads ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Fibonacci tools like Fibonacci Retracement and Fibonacci Time Zones, are popular with both new and professional traders because they make it easier to spot potential support and resistance levels. In ...

Leonardo Fibonacci was a mathematician who lived in Italy hundreds of years ago. Although the sequence was known to non-Westerners long before, during the 13th century it’s thought that Fibonacci ...

Fibonacci retracement maps pullback levels at 23.6%, 38.2%, 50%, 61.8%, and 78.6%, derived from ratios in the Fibonacci sequence identified by Leonardo Fibonacci in the 13th century. The 61.8% level, ...

Recursive Superintelligence, a London and San Francisco-based artificial intelligence startup, has officially emerged from stealth with a $650 million Series A funding round. Founded in 2026, ...

Meta is testing a new “Series” feature for Reels that’s designed to make it easier to keep up with serialized content on Instagram and Facebook, the company told TechCrunch. Select creators will now ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...